Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium

M. Anthony, K. Romero, Daniel C Malone, L. E. Hines, L. Higgins, R. L. Woosley

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Interactions of warfarin with other drugs or substances can pose a serious problem. We assessed three drug information compendiaClinical Pharmacology, ePocrates, and Micromedexand the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements. The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin. Of a total of 648 entries from the four sources, only 50 were common to all the sources. The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco. These sources were then examined for classification by severity of interaction and the underlying evidence base. This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin.

Original languageEnglish (US)
Pages (from-to)425-429
Number of pages5
JournalClinical Pharmacology and Therapeutics
Volume86
Issue number4
DOIs
StatePublished - Oct 2009

Fingerprint

Warfarin
Pharmaceutical Preparations
Dietary Supplements
Biological Products
Drug Combinations
United States Food and Drug Administration
Tobacco
Alcohols
Pharmacology
Food

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium. / Anthony, M.; Romero, K.; Malone, Daniel C; Hines, L. E.; Higgins, L.; Woosley, R. L.

In: Clinical Pharmacology and Therapeutics, Vol. 86, No. 4, 10.2009, p. 425-429.

Research output: Contribution to journalArticle

@article{4c1ce52fa109415091727119d5b93cab,
title = "Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium",
abstract = "Interactions of warfarin with other drugs or substances can pose a serious problem. We assessed three drug information compendiaClinical Pharmacology, ePocrates, and Micromedexand the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements. The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin. Of a total of 648 entries from the four sources, only 50 were common to all the sources. The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco. These sources were then examined for classification by severity of interaction and the underlying evidence base. This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin.",
author = "M. Anthony and K. Romero and Malone, {Daniel C} and Hines, {L. E.} and L. Higgins and Woosley, {R. L.}",
year = "2009",
month = "10",
doi = "10.1038/clpt.2009.95",
language = "English (US)",
volume = "86",
pages = "425--429",
journal = "Clinical Pharmacology and Therapeutics",
issn = "0009-9236",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Warfarin interactions with substances listed in drug information compendia and in the FDA-approved label for warfarin sodium

AU - Anthony, M.

AU - Romero, K.

AU - Malone, Daniel C

AU - Hines, L. E.

AU - Higgins, L.

AU - Woosley, R. L.

PY - 2009/10

Y1 - 2009/10

N2 - Interactions of warfarin with other drugs or substances can pose a serious problem. We assessed three drug information compendiaClinical Pharmacology, ePocrates, and Micromedexand the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements. The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin. Of a total of 648 entries from the four sources, only 50 were common to all the sources. The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco. These sources were then examined for classification by severity of interaction and the underlying evidence base. This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin.

AB - Interactions of warfarin with other drugs or substances can pose a serious problem. We assessed three drug information compendiaClinical Pharmacology, ePocrates, and Micromedexand the warfarin sodium (Coumadin) product label (August 2007) approved by the US Food and Drug Administration for listings of interactions between warfarin and drugs, biologics, foods, and dietary supplements. The drug information compendia and warfarin label differed greatly as to the total number of substances that interact with warfarin. Of a total of 648 entries from the four sources, only 50 were common to all the sources. The types of substances listed as interacting with warfarin were entire classes of drugs, individual drugs, and combinations; biologics; dietary supplements; foods; alcohol; and tobacco. These sources were then examined for classification by severity of interaction and the underlying evidence base. This study provides evidence that there is little concordance among commonly used drug compendia and product labels with respect to interactions involving warfarin.

UR - http://www.scopus.com/inward/record.url?scp=70349443540&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349443540&partnerID=8YFLogxK

U2 - 10.1038/clpt.2009.95

DO - 10.1038/clpt.2009.95

M3 - Article

C2 - 19587643

AN - SCOPUS:70349443540

VL - 86

SP - 425

EP - 429

JO - Clinical Pharmacology and Therapeutics

JF - Clinical Pharmacology and Therapeutics

SN - 0009-9236

IS - 4

ER -